Logo image of PINK.CA

PERIMETER MEDICAL IMAGING AI (PINK.CA) Stock Fundamental Analysis

TSX-V:PINK - TSX Venture Exchange - CA71385D1078 - Common Stock - Currency: CAD

0.235  +0 (+2.17%)

Fundamental Rating

3

Taking everything into account, PINK scores 3 out of 10 in our fundamental rating. PINK was compared to 14 industry peers in the Health Care Equipment & Supplies industry. PINK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PINK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year PINK has reported negative net income.
PINK had a negative operating cash flow in the past year.
PINK had negative earnings in each of the past 5 years.
In the past 5 years PINK always reported negative operating cash flow.
PINK.CA Yearly Net Income VS EBIT VS OCF VS FCFPINK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

PINK has a Return On Assets of -182.16%. This is in the lower half of the industry: PINK underperforms 64.29% of its industry peers.
Looking at the Return On Equity, with a value of -239.96%, PINK is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
Industry RankSector Rank
ROA -182.16%
ROE -239.96%
ROIC N/A
ROA(3y)-63.49%
ROA(5y)-88.85%
ROE(3y)-86.41%
ROE(5y)-118.03%
ROIC(3y)N/A
ROIC(5y)N/A
PINK.CA Yearly ROA, ROE, ROICPINK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

PINK has a better Gross Margin (60.63%) than 78.57% of its industry peers.
PINK's Gross Margin has improved in the last couple of years.
PINK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.47%
GM growth 5YN/A
PINK.CA Yearly Profit, Operating, Gross MarginsPINK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50K -100K

More info and screens

5

2. Health

2.1 Basic Checks

PINK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PINK has been increased compared to 1 year ago.
The number of shares outstanding for PINK has been increased compared to 5 years ago.
PINK has a worse debt/assets ratio than last year.
PINK.CA Yearly Shares OutstandingPINK.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PINK.CA Yearly Total Debt VS Total AssetsPINK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

PINK has an Altman-Z score of -16.77. This is a bad value and indicates that PINK is not financially healthy and even has some risk of bankruptcy.
PINK has a Altman-Z score (-16.77) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.01 indicates that PINK is not too dependend on debt financing.
PINK's Debt to Equity ratio of 0.01 is amongst the best of the industry. PINK outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -16.77
ROIC/WACCN/A
WACC7.72%
PINK.CA Yearly LT Debt VS Equity VS FCFPINK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 2.52 indicates that PINK has no problem at all paying its short term obligations.
The Current ratio of PINK (2.52) is better than 85.71% of its industry peers.
PINK has a Quick Ratio of 2.41. This indicates that PINK is financially healthy and has no problem in meeting its short term obligations.
PINK has a better Quick ratio (2.41) than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 2.41
PINK.CA Yearly Current Assets VS Current LiabilitesPINK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for PINK have decreased by -2.56% in the last year.
The Revenue has grown by 231.40% in the past year. This is a very strong growth!
PINK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 354.72% yearly.
EPS 1Y (TTM)-2.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80%
Revenue 1Y (TTM)231.4%
Revenue growth 3Y354.72%
Revenue growth 5YN/A
Sales Q2Q%497.73%

3.2 Future

The Earnings Per Share is expected to grow by 19.59% on average over the next years. This is quite good.
PINK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 119.37% yearly.
EPS Next Y-13.62%
EPS Next 2Y3.94%
EPS Next 3Y7.14%
EPS Next 5Y19.59%
Revenue Next Year270.79%
Revenue Next 2Y224.86%
Revenue Next 3Y180.07%
Revenue Next 5Y119.37%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PINK.CA Yearly Revenue VS EstimatesPINK.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
PINK.CA Yearly EPS VS EstimatesPINK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4 0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PINK. In the last year negative earnings were reported.
Also next year PINK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PINK.CA Price Earnings VS Forward Price EarningsPINK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PINK.CA Per share dataPINK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.94%
EPS Next 3Y7.14%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PINK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERIMETER MEDICAL IMAGING AI

TSX-V:PINK (6/13/2025, 7:00:00 PM)

0.235

+0 (+2.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-12 2025-08-12
Inst Owners33.2%
Inst Owner ChangeN/A
Ins Owners13.82%
Ins Owner ChangeN/A
Market Cap21.97M
Analysts80
Price Target1.87 (695.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-42.57%
Min EPS beat(2)-66.34%
Max EPS beat(2)-18.81%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)80.94%
Min Revenue beat(2)1.49%
Max Revenue beat(2)160.4%
Revenue beat(4)4
Avg Revenue beat(4)57.97%
Min Revenue beat(4)1.49%
Max Revenue beat(4)160.4%
Revenue beat(8)5
Avg Revenue beat(8)8.46%
Revenue beat(12)6
Avg Revenue beat(12)-2.83%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.34%
PT rev (3m)-8.34%
EPS NQ rev (1m)-16.52%
EPS NQ rev (3m)-16.52%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.42
P/FCF N/A
P/OCF N/A
P/B 2.48
P/tB 2.48
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0.02
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -182.16%
ROE -239.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.63%
FCFM N/A
ROA(3y)-63.49%
ROA(5y)-88.85%
ROE(3y)-86.41%
ROE(5y)-118.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.47%
GM growth 5YN/A
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.52
Quick Ratio 2.41
Altman-Z -16.77
F-Score3
WACC7.72%
ROIC/WACCN/A
Cap/Depr(3y)208.17%
Cap/Depr(5y)571.74%
Cap/Sales(3y)624.9%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80%
EPS Next Y-13.62%
EPS Next 2Y3.94%
EPS Next 3Y7.14%
EPS Next 5Y19.59%
Revenue 1Y (TTM)231.4%
Revenue growth 3Y354.72%
Revenue growth 5YN/A
Sales Q2Q%497.73%
Revenue Next Year270.79%
Revenue Next 2Y224.86%
Revenue Next 3Y180.07%
Revenue Next 5Y119.37%
EBIT growth 1Y-7.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-4.87%
EBIT Next 3Y15.32%
EBIT Next 5Y23.3%
FCF growth 1Y-20.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.83%
OCF growth 3YN/A
OCF growth 5YN/A